Işın Üreyen

702 total citations
64 papers, 418 citations indexed

About

Işın Üreyen is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Surgery. According to data from OpenAlex, Işın Üreyen has authored 64 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Obstetrics and Gynecology, 41 papers in Reproductive Medicine and 18 papers in Surgery. Recurrent topics in Işın Üreyen's work include Endometrial and Cervical Cancer Treatments (40 papers), Ovarian cancer diagnosis and treatment (29 papers) and Endometriosis Research and Treatment (18 papers). Işın Üreyen is often cited by papers focused on Endometrial and Cervical Cancer Treatments (40 papers), Ovarian cancer diagnosis and treatment (29 papers) and Endometriosis Research and Treatment (18 papers). Işın Üreyen collaborates with scholars based in Türkiye and United States. Işın Üreyen's co-authors include Taner Turan, Alper Karalök, Gökhan Tulunay, Tolga Taşçı, Nurettin Boran, Osman Türkmen, Derman Başaran, Mehmet Faruk Köse, Günsu Kimyon Cömert and Derya Akdağ Cırık and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gynecologic Oncology and International Journal of Gynecology & Obstetrics.

In The Last Decade

Işın Üreyen

55 papers receiving 411 citations

Peers

Işın Üreyen
P.J. DiSaia United States
Pedro T. Ramirez United States
Mustafa Özat Türkiye
Ali Yavuzcan Türkiye
Işın Üreyen
Citations per year, relative to Işın Üreyen Işın Üreyen (= 1×) peers Gökhan Boyraz

Countries citing papers authored by Işın Üreyen

Since Specialization
Citations

This map shows the geographic impact of Işın Üreyen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Işın Üreyen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Işın Üreyen more than expected).

Fields of papers citing papers by Işın Üreyen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Işın Üreyen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Işın Üreyen. The network helps show where Işın Üreyen may publish in the future.

Co-authorship network of co-authors of Işın Üreyen

This figure shows the co-authorship network connecting the top 25 collaborators of Işın Üreyen. A scholar is included among the top collaborators of Işın Üreyen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Işın Üreyen. Işın Üreyen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Süren, Dinç, et al.. (2024). The frequency and prognostic role of P53 and P16 immunoexpression in primary ovarian mucinous tumors. Annals of Diagnostic Pathology. 72. 152330–152330. 1 indexed citations
3.
Üreyen, Işın, et al.. (2024). β‑catenin expression in endometrioid type endometrial cancer: Expression patterns and impact on disease outcomes. Oncology Letters. 28(6). 580–580. 2 indexed citations
4.
Toptaş, Tayfun, et al.. (2024). Impact of preoperative carbohydrate loading on postoperative course and morbidity in debulking surgery for epithelial ovarian cancer. Experimental and Therapeutic Medicine. 27(5). 181–181.
5.
Toptaş, Tayfun, et al.. (2021). Obstetrician-gynecologists’ practice patterns regarding HPV testing in cervical cancer screening in Turkey. Journal of Turkish Society of Obstetric and Gynecology. 18(1). 15–22.
6.
Üreyen, Işın, Alper Karalök, Osman Türkmen, et al.. (2019). Factors predicting recurrence in patients with stage IA endometrioid endometrial cancer: what is the importance of LVSI?. Archives of Gynecology and Obstetrics. 301(3). 737–744. 11 indexed citations
7.
Boyraz, Gökhan, İrfan Çiçin, Oğuzhan Kuru, et al.. (2019). Prognostic factors and oncological outcomes of ovarian yolk sac tumors: a retrospective multicentric analysis of 99 cases. Archives of Gynecology and Obstetrics. 300(1). 175–182. 4 indexed citations
8.
Türkmen, Osman, Alper Karalök, Derman Başaran, et al.. (2017). Revaluating survival effects of FIGO 1988 stage IIIA criteria for endometrial cancer. Journal of the Turkish-German Gynecological Association. 18(3). 110–115. 2 indexed citations
9.
Üreyen, Işın, Alper Karalök, Derya Akdağ Cırık, et al.. (2017). Uterine and Ovarian Carcinosarcomas: Do They Behave Similarly?. Journal of Obstetrics and Gynaecology Canada. 39(7). 559–563. 3 indexed citations
10.
Köse, Mehmet Faruk, Günsu Kimyon Cömert, Müfit Cemal Yenen, et al.. (2017). Extraperitoneal lymph node dissection in locally advanced cervical cancer; the prognostic factors associated with survival. Journal of the Turkish-German Gynecological Association. 18(2). 77–84. 4 indexed citations
11.
Toptaş, Tayfun, Alper Karalök, Işın Üreyen, et al.. (2016). Liver recurrence in endometrial cancer: a multi-institutional analysis of factors predictive of postrecurrence survival. Clinical & Experimental Metastasis. 33(7). 707–715. 3 indexed citations
12.
Karalök, Alper, Derman Başaran, Işın Üreyen, et al.. (2016). Does synchronous endometrioid endometrial cancer have any prognostic effect on Stage I endometrioid ovarian cancer?. European Journal of Obstetrics & Gynecology and Reproductive Biology. 200. 113–116. 6 indexed citations
13.
Kavak, Duygu, Işın Üreyen, Alper Karalök, et al.. (2016). Mucinous borderline ovarian tumors: Analysis of 75 patients from a single center. Journal of the Turkish-German Gynecological Association. 17(2). 96–100. 5 indexed citations
14.
Taşçı, Tolga, Alper Karalök, Salih Taşkın, et al.. (2015). Does Lymphadenectomy Improve Survival in Uterine Leiomyosarcoma?. International Journal of Gynecological Cancer. 25(6). 1031–1036. 9 indexed citations
15.
Cırık, Derya Akdağ, Alper Karalök, Işın Üreyen, et al.. (2015). Early and Late Complications after Inguinofemoral Lymphadenectomy for Vulvar Cancer. Asian Pacific Journal of Cancer Prevention. 16(13). 5175–5179. 17 indexed citations
16.
Üreyen, Işın, Taner Turan, Derya Akdağ Cırık, et al.. (2014). Frozen section in borderline ovarian tumors: is it reliable?. European Journal of Obstetrics & Gynecology and Reproductive Biology. 181. 115–118. 16 indexed citations
17.
Turan, Taner, Işın Üreyen, Enis Özkaya, et al.. (2014). Analysis of Patients With Stage IIIC Endometrial Cancer. International Journal of Gynecological Cancer. 24(6). 1033–1041. 11 indexed citations
18.
Üreyen, Işın, Alper Karalök, Taner Turan, et al.. (2013). Small cell carcinoma of the endometrium: A report of three cases. Journal of the Turkish-German Gynecological Association. 14(2). 113–113. 11 indexed citations
19.
Karalök, Alper, Işın Üreyen, Taner Turan, et al.. (2013). Case report: Methotrexate-induced pericardial effusion. Journal of the Turkish-German Gynecological Association. 14(1). 48–49. 4 indexed citations
20.
Tulunay, Gökhan, Işın Üreyen, Alper Karalök, Taner Turan, & Nurettin Boran. (2012). A ptotic kidney with multiple arteries, one from a common renal artery stem. Asian Pacific Journal of Reproduction. 1(4). 318–319. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026